Navenot J[au] - Search Results

Year	Number of Results
1993	1
1994	2
1995	1
1996	1
1997	3
1998	3
1999	1
2000	1
2001	1
2002	3
2003	2
2005	2
2006	3
2007	4
2008	1
2009	2
2010	1
2012	3
2013	1
2014	1
2017	1
2018	2
2019	2
2021	0

1

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

O'Rourke DM, Nasrallah MP, Desai A, Melenhorst JJ, Mansfield K, Morrissette JJD, Martinez-Lage M, Brem S, Maloney E, Shen A, Isaacs R, Mohan S, Plesa G, Lacey SF, Navenot JM, Zheng Z, Levine BL, Okada H, June CH, Brogdon JL, Maus MV. O'Rourke DM, et al. Among authors: navenot jm. Sci Transl Med. 2017 Jul 19;9(399):eaaa0984. doi: 10.1126/scitranslmed.aaa0984. Sci Transl Med. 2017. PMID: 28724573 Free PMC article. Clinical Trial.

2

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 ^c259T Cells in Synovial Sarcoma.

D'Angelo SP, Melchiori L, Merchant MS, Bernstein D, Glod J, Kaplan R, Grupp S, Tap WD, Chagin K, Binder GK, Basu S, Lowther DE, Wang R, Bath N, Tipping A, Betts G, Ramachandran I, Navenot JM, Zhang H, Wells DK, Van Winkle E, Kari G, Trivedi T, Holdich T, Pandite L, Amado R, Mackall CL. D'Angelo SP, et al. Among authors: navenot jm. Cancer Discov. 2018 Aug;8(8):944-957. doi: 10.1158/2159-8290.CD-17-1417. Epub 2018 Jun 11. Cancer Discov. 2018. PMID: 29891538 Free PMC article. Clinical Trial.

3

Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma.

Ramachandran I, Lowther DE, Dryer-Minnerly R, Wang R, Fayngerts S, Nunez D, Betts G, Bath N, Tipping AJ, Melchiori L, Navenot JM, Glod J, Mackall CL, D'Angelo SP, Araujo DM, Chow WA, Demetri GD, Druta M, Van Tine BA, Grupp SA, Abdul Razak AR, Wilky B, Iyengar M, Trivedi T, Winkle EV, Chagin K, Amado R, Binder GK, Basu S. Ramachandran I, et al. Among authors: navenot jm. J Immunother Cancer. 2019 Oct 24;7(1):276. doi: 10.1186/s40425-019-0762-2. J Immunother Cancer. 2019. PMID: 31651363 Free PMC article.

4

Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.

Stadtmauer EA, Faitg TH, Lowther DE, Badros AZ, Chagin K, Dengel K, Iyengar M, Melchiori L, Navenot JM, Norry E, Trivedi T, Wang R, Binder GK, Amado R, Rapoport AP. Stadtmauer EA, et al. Among authors: navenot jm. Blood Adv. 2019 Jul 9;3(13):2022-2034. doi: 10.1182/bloodadvances.2019000194. Blood Adv. 2019. PMID: 31289029 Free PMC article.

5

Effects of developmental lead exposure on the hippocampal methylome: Influences of sex and timing and level of exposure.

Singh G, Singh V, Wang ZX, Voisin G, Lefebvre F, Navenot JM, Evans B, Verma M, Anderson DW, Schneider JS. Singh G, et al. Among authors: navenot jm. Toxicol Lett. 2018 Jun 15;290:63-72. doi: 10.1016/j.toxlet.2018.03.021. Epub 2018 Mar 20. Toxicol Lett. 2018. PMID: 29571894 Free PMC article.

6

Heme oxygenase-1 gene promoter polymorphism is associated with the development of necrotizing acute pancreatitis.

Gulla A, Evans BJ, Navenot JM, Pundzius J, Barauskas G, Gulbinas A, Dambrauskas Z, Arafat H, Wang ZX. Gulla A, et al. Among authors: navenot jm. Pancreas. 2014 Nov;43(8):1271-6. doi: 10.1097/MPA.0000000000000171. Pancreas. 2014. PMID: 25036905

7

Characterization of the receptor binding residues of kisspeptins by positional scanning using peptide photoaffinity probes.

Misu R, Oishi S, Setsuda S, Noguchi T, Kaneda M, Ohno H, Evans B, Navenot JM, Peiper SC, Fujii N. Misu R, et al. Among authors: navenot jm. Bioorg Med Chem Lett. 2013 May 1;23(9):2628-31. doi: 10.1016/j.bmcl.2013.02.098. Epub 2013 Mar 4. Bioorg Med Chem Lett. 2013. PMID: 23522565

8

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.

Solomides CC, Evans BJ, Navenot JM, Vadigepalli R, Peiper SC, Wang ZX. Solomides CC, et al. Among authors: navenot jm. Acta Cytol. 2012;56(6):645-54. doi: 10.1159/000343473. Epub 2012 Nov 24. Acta Cytol. 2012. PMID: 23207443

9

Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists.

Masuda R, Oishi S, Tanahara N, Ohno H, Hirasawa A, Tsujimoto G, Yano Y, Matsuzaki K, Navenot JM, Peiper SC, Fujii N. Masuda R, et al. Among authors: navenot jm. Bioconjug Chem. 2012 Jun 20;23(6):1259-65. doi: 10.1021/bc300084h. Epub 2012 May 9. Bioconjug Chem. 2012. PMID: 22486464

10

Structure-activity relationship study on small peptidic GPR54 agonists.

Tomita K, Niida A, Oishi S, Ohno H, Cluzeau J, Navenot JM, Wang ZX, Peiper SC, Fujii N. Tomita K, et al. Among authors: navenot jm. Bioorg Med Chem. 2006 Nov 15;14(22):7595-603. doi: 10.1016/j.bmc.2006.07.009. Epub 2006 Aug 1. Bioorg Med Chem. 2006. PMID: 16879969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results